Legend Biotech Corporation

US$23.40As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:LEGNHealthcare
Country USA
PE (Fwd) •••
TSR 6Y CAGR (8.98%)
Div yield —
ROE (8.08%)
Biotechnology
Beta (5Y) 0.55
PE TTM —
TSR TTM (27.78%)
Mkt cap US$4.534B
ROIC (9.91%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$23
(0.05%)
(50.39%)
Hold 5|2|3|2|1
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.30
0.31
0.30
0.32
9.41%
1.28%
0.58%
10.11%
Revenue$M
265.4
267.2
275.5
272.6
4.00%
7.51%
13.54%
6.51%
Peers (US$4.534B)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
0.183
(0.360)
(0.340)
EBIT/Intx
0.170
0.137
0.157
Own earn%
56.82
29.77
28.94
Sh yield%
51.44
33.66
33.26
Owners
Insiders/Inst%
14.12
63.60
Short interest%
5.27
SBC / revenue%
2.18
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
17
Op margin range%
22–30
$1 testx
—
Incr. ROIC%
3